Brief: Natera To Scale AI Foundation Models In Precision Medicine With Nvidia
12/01/2026 16:10
Jan 12 (Reuters) - Natera Inc NTRA.O: NATERA TO SCALE AI FOUNDATION MODELS IN PRECISION MEDICINE WITH NVIDIA Source text: ID:nBw5Wvnl2a Further company coverage: NTRA.O (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers